Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Analyzing Tenet Healthcare's third-quarter 2024 earnings, the revenue figures are telling: a 15% increase in adjusted EBITDA of $978 million and net operating revenues hitting $5.1 billion, reflecting a sustained positive trajectory.</li><li>Key growth drivers were highlighted across various segments.</li><li>USPI, for instance, continued its assertive expansion with revenue growth of 8.7% in its facilities, with new developments and partnerships, particularly the new joint venture in San Diego, fostering further optimism about its growth prospects.</li></ul>

Analyzing Tenet Healthcare's third-quarter 2024 earnings, the revenue figures are telling: a 15% increase in adjusted EBITDA of $978 million and net operating revenues hitting $5.1 billion, reflecting a sustained positive trajectory.Key growth drivers were highlighted across various segments.USPI, for instance, continued its assertive expansion with revenue growth of 8.7% in its facilities, with new developments and partnerships, particularly the new joint venture in San Diego, fostering further optimism about its growth prospects.

Tenet Healthcare Corporation: Expansion of Acute Care Services & Other Major Drivers

<ul><li>Tenet Healthcare Corporation delivered robust financial results in the second quarter of 2024, surpassing expectations with net operating revenues recorded at $5.1 billion.</li><li>The performance was marked by a notable 12% year-over-year growth in consolidated adjusted EBITDA, which reached $945 million, translating to an adjusted EBITDA margin of 18.5%.</li><li>This growth is primarily attributed to strong operational execution and strategic expansions across its segments.</li></ul>

Tenet Healthcare Corporation delivered robust financial results in the second quarter of 2024, surpassing expectations with net operating revenues recorded at $5.1 billion.The performance was marked by a notable 12% year-over-year growth in consolidated adjusted EBITDA, which reached $945 million, translating to an adjusted EBITDA margin of 18.5%.This growth is primarily attributed to strong operational execution and strategic expansions across its segments.

Tenet Healthcare Corporation: Focus on Ambulatory Surgical Centers (ASC) Growth & Enhanced Operational Management! - Major Drivers

<ul><li>In the first quarter of 2024 earnings, Tenet Healthcare Corp delivered an overview of their recent performance and future outlook.</li><li>The company closed the sale of nine hospitals for pre-tax proceeds of $4 billion, which has allowed for retirement of debt and a significant reduction in their leverage ratio.</li><li>The lessened liabilities help Tenet to continue investing in its ambulatory care program, thereby improving their capital efficiency and profitability.</li></ul>

In the first quarter of 2024 earnings, Tenet Healthcare Corp delivered an overview of their recent performance and future outlook.The company closed the sale of nine hospitals for pre-tax proceeds of $4 billion, which has allowed for retirement of debt and a significant reduction in their leverage ratio.The lessened liabilities help Tenet to continue investing in its ambulatory care program, thereby improving their capital efficiency and profitability.

Tenet Healthcare Corporation: What Is Their Biggest Competitive Advantage? - Major Drivers

<ul><li>Tenet Healthcare's Q4 2023 earnings indicated a strong performance, with net operating revenues of $20.5 billion, and consolidated adjusted EBITDA of $3.54 billion, which translates into an attractive 17.2% adjusted EBITDA margin.</li><li>The company has demonstrated its ability to maintain profitability while focusing on quality and innovation.</li><li>Yet, some challenges were also mentioned during the earnings call.</li></ul>

Tenet Healthcare's Q4 2023 earnings indicated a strong performance, with net operating revenues of $20.5 billion, and consolidated adjusted EBITDA of $3.54 billion, which translates into an attractive 17.2% adjusted EBITDA margin.The company has demonstrated its ability to maintain profitability while focusing on quality and innovation.Yet, some challenges were also mentioned during the earnings call.

Tenet Healthcare Corporation: Initiation Of Coverage - Its Focus on Higher Acuity Services in Hospitals & Other Core Strategies! - Major Drivers

Global Healthcare Analyst

Tina Banerjee

<ul>
<li>
<a href="https://www.smartkarma.com/entities/asahi-intecc-co-ltd" target="_blank" data-smartkarma-citation="entities:15915:1" rel="noopener">Asahi Intecc (7747 JP)</a> is poised for multi-year growth through strong market demand for its technically superior guidewires, market leadership positioning, new product launches, and direct marketing initiatives.</li>
<li>In FY24, Asahi Intecc aims to achieve revenue of ¥100B (+11% YoY), a significant milestone. The company targets revenue of ¥110B and an operating profit margin of 23–25% in FY26.</li>
<li>Asahi Intecc is expected to be a continued beneficiary of global procedure volume recovery. The company is likely to achieve its medium-term business plan ahead of schedule.</li>
</ul>



Asahi Intecc (7747 JP) is poised for multi-year growth through strong market demand for its technically superior guidewires, market leadership positioning, new product launches, and direct marketing initiatives.
In FY24, Asahi Intecc aims to achieve revenue of ¥100B (+11% YoY), a significant milestone. The company targets revenue of ¥110B and an operating profit margin of 23–25% in FY26.
Asahi Intecc is expected to be a continued beneficiary of global procedure volume recovery. The company is likely to achieve its medium-term business plan ahead of schedule.


2024 High Conviction: Asahi Intecc (7747 JP)- Procedure Volume Recovery to Accelerate Growth

United States

Tenet Healthcare Corporation, through its subsidiaries, owns or operates general hospitals and related health care facilities serving communities in the United States.  The Company operates rehabilitation hospitals, specialty hospitals, long-term care facilities, psychiatric facilities, and medical office buildings near its general hospitals, as well as ancillary health care businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tenet Healthcare (THC US)

Tenet Healthcare Corporation: Expansion of Acute Care Services & Other Major Drivers

Analyzing Tenet Healthcare's third-quarter 2024 earnings, the revenue figures are telling: a 15% increase in adjusted EBITDA of $978 million and...

Baptista Research

Tenet Healthcare Corporation: Focus on Ambulatory Surgical Centers (ASC) Growth & Enhanced Operational Management! - Major Drivers

Tenet Healthcare Corporation delivered robust financial results in the second quarter of 2024, surpassing expectations with net operating revenues...

Baptista Research

Tenet Healthcare Corporation: What Is Their Biggest Competitive Advantage? - Major Drivers

In the first quarter of 2024 earnings, Tenet Healthcare Corp delivered an overview of their recent performance and future outlook. The company...

Baptista Research

Tenet Healthcare Corporation: Initiation Of Coverage - Its Focus on Higher Acuity Services in Hospitals & Other Core Strategies! - Major Drivers

Tenet Healthcare's Q4 2023 earnings indicated a strong performance, with net operating revenues of $20.5 billion, and consolidated adjusted EBITDA...

Baptista Research

2024 High Conviction: Asahi Intecc (7747 JP)- Procedure Volume Recovery to Accelerate Growth

Asahi Intecc is poised for double-digit sales growth through FY26, driven by strong market demand for guidewires, market leadership positioning,...

Tina Banerjee

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)